The RKO-AS45-1 cell line was generated from the colon carcinoma RKO cell line by transfection with the open reading frame portions of human cDNAs for GADD45...
This cell line was established from a local recurrence of a sacrococcygeal after radiotherapy 4 years after initial surgery.
Established from the bone marrow of a 27-year-old woman with B-cell non-Hodgkin lymphoma (B-NHL) (diffuse large cell lymphoma, DLCL, stage 4B, at relapse) in...
Established in 1988 from the pleural fluid of a 56-year-old man with diffuse large B cell lymphoma (DLBCL, stage IIIB, at relapse)
Established from the bone marrow of a 44-year-old man with B-cell non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983; assigned to...
NK-92MI is an interleukin-2 (IL-2) independent Natural Killer Cell line derived from the NK-92 cell line by transfection.
NCCIT was established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor.
The parent cell line, MM.1, was established from peripheral blood of a multiple myeloma patient who had become resistant to steroid-based therapy.
The parent cell line, MM.1, was established from peripheral blood of a multiple myeloma patient who had become resistant to steroid-based therapy.
The line was established from normal skin taken at biopsy from the left breast.
The A253 line is one of thirteen to be isolated and partially characterized through trial studies on a series of 200 human tumors.
The MEG-01 cell line was derived in 1983 at the Nagoya University School of Medicine, Nagoya, Japan from bone marrow cells taken from a patient in...
This line was established by transfection of limb tissue obtained from a spontaneous miscarriage with the temperature sensitive expression vector pUCSVtsA58...
An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen (HLA)-typing data available.
Rolf B1.T cells arose from a spontaneous immortalisation event - retaining characteristics of normal cells. The cells are dependent on serum growth factors...
This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin...
The drug resistant cell line K562 AZQ has been developed from the parent K562 cell line by treatment with AZQ C215-bis (carboethoxyamino)-3, 6-diazitinyl 1;4...